Ginkgo Bioworks Holdings, Inc. (DNA)

USD 8.36

(2.96%)

Gross Profit Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual gross profit in 2023 was 197.45 Million USD , down -47.84% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly gross profit in 2024 Q1 was 15.87 Million USD , down -15.6% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a annual gross profit of 273.49 Million USD in annual gross profit 2022, up 48.52% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a annual gross profit of 184.14 Million USD in annual gross profit 2021, up 201.65% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly gross profit of 25.15 Million USD for 2024 Q2, up 58.48% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly gross profit of 48.5 Million USD for 2023 Q3, down -22.35% from previous quarter.

Annual Gross Profit Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Gross Profit of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Gross Profit Gross Profit Growth
2023 197.45 Million USD -47.84%
2022 273.49 Million USD 48.52%
2021 184.14 Million USD 201.65%
2020 61.04 Million USD 12.66%
2019 54.18 Million USD 0.0%
2001 98.28 Million USD 0.0%

Peer Gross Profit Comparison of Ginkgo Bioworks Holdings, Inc.

Name Gross Profit Gross Profit Difference
ADC Therapeutics SA 67.02 Million USD -194.574%
Alto Neuroscience, Inc. -373 Thousand USD 53035.657%
Annovis Bio, Inc. - USD -Infinity%
Biohaven Pharmaceutical Holding Company Ltd. -3.36 Million USD 5960.79%
Nuvation Bio Inc. -222 Thousand USD 89041.441%
Nuvation Bio Inc. -222 Thousand USD 89041.441%
Arcus Biosciences, Inc. -223 Million USD 188.543%
Zymeworks Inc. -66.97 Million USD 394.803%